CapsoVision, Inc. ( (CV) ) has shared an announcement.

The AI in endoscopy market is driven by rising gastrointestinal diseases and a shift to minimally invasive procedures. Key ...

Researchers in Germany and Austria have developed a dual-imaging endoscopy capsule technique, dubbed O2E, that more accurately detects precancerous and cancerous changes in the esophagus. The team ...

CapsoVision, Inc. announces its IPO, pricing 5.5 million shares at $5.00 each, trading on Nasdaq from July 2, 2025. CapsoVision, Inc., a medical technology company specializing in advanced imaging and ...

A Johns Hopkins University-led research team has developed a pill-sized capsule that, when swallowed by a patient, can diagnose, monitor, and treat gastrointestinal diseases including Barrett's ...

Please provide your email address to receive an email when new articles are posted on . Gastric transit time was significantly longer in the GLP-1RA group vs. the control group (99.3 minutes vs. 25.3 ...

1. Gastro Concepts secured FDA clearance for Air Assist in December, a device designed to prevent air and carbon dioxide from escaping during colonoscopy+3. The device maintains colonic distension for ...

Gastrointestinal (GI) diseases, whose symptoms can be varied and painful, may lead to serious health problems, and present a formidable health challenge throughout the world. For these diseases, early ...